Cluster Excellence for Business, Innovation and Growth in the health sector
CE4BIG
Overview
Type of partnership
Partnership duration (months)
Number of partners
Number of planned exchanges
Summary and objectives
Relying on their regional smart specialization priorities, 4 health clusters supporting the development of advanced therapies for personalized medicine (Atlanpole Biotherapies-FR, BioM-DE, BIOWIN-BE, Klaster Life Science Krakow-PL) will work in synergy to: - achieve cluster/sectoral comparative analyses to pinpoint synergies, common weaknesses and areas of improvement, - enhance cluster’ management skills and strategy through customized trainings and transnational missions for C2C learning on topics of common interest for SMEs stemming from benchmarking, - stimulate dialogue between their SME members and business/innovation support stakeholders within the consortium and beyond thanks to short-term exchanges through the ClusterXchange scheme, - design a joint strategic plan to ensure sustainability of the partnership. The aim is to build on lessons learned and experience gained to provide start-ups/SMEs in the health sector with top-quality and professional services and to help them capitalize on cross-sectoral partnering and seize opportunities available beyond regional borders in order to innovate, grow abroad, face global competition and meet the challenge of personalized medicine.
Results expected
Expected impact entails : - Award of 4 Cluster Management Excellence labels further to benchmarking i.e. Bronze (ABT), Silver (BIOWIN, KLSK) and Gold renewal (BioM) - 8 cluster managers trained to improve their management skills - 4 transnational missions organized to foster C2C peer-learning and SME business, innovation and growth - 52 short-term exchanges achieved via the ClusterXchange scheme, of which 50% (26) entail SMEs, 25% (13) participants outside the consortium and 7% (4) cluster staff for C2C learning - 4 individual cluster and 1 partnership strategic plans revisited and designed respectively - wide dissemination of outputs namely short-term exchange success stories to value the ClusterXchange scheme for spill-over effect.
Sectorial and industrial focus
Sectoral industries
Cross-sectoral industries
Industrial Alliances and Ecosystems
Technology fields
S3 EU priority areas
Areas of specialisation not covered above
- The CE4BIG project covers all fields of Personalised Medecine.
- Apart from Biopharmaceuticals, the project also focuses on another emerging industry i.e. Medical devices.
Partnership composition
| Profile name | Location | Project coordinator | |
|---|---|---|---|
| BioWin |
Belgium
|
||
| Klaster LifeScience Krakow |
Poland
|
||
| Atlanpole Biotherapies |
France
|
||
| BioM Biotech Cluster Development GmbH |
Germany
|
Other linked key partners or networks
| Profile name | Location | Network type | |
|---|---|---|---|
| CEBR |
Belgium
|
Upcoming events
| Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday |
|---|---|---|---|---|---|---|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
1
|
2
|
3
|
4
|
| |
|
|
|
Latest news and documents
There is no uploaded content...
Submitted best practices
There is no uploaded content...